Friday November 27 2009 | Biotechnology feed | All feeds
|
|
PDL BioPharma, Inc.http://www.pdl.com/ Protein Design Labs Incorporated, Freemont CA, United States of America. PDL is a leader in the development of humanized monoclonal antibodies for the prevention and treatment of a variety of disease conditions. PDL currently has antibodies under development for autoimmune Ticker - PDL BioPharma Provides Second Quarter 2009 Revenue Guidance of Approximately $125 MillionMonday 8th of June 2009 8:30BioPortfolio no longer holds the full text of this article, it is however likley to be available via the below links:
![]() Browse other news from this organisation: PDL BioPharma, Inc. Related Web-Links(If any, Generated Automatically)
Source PR Newswire |
|